SCHEMBL217151

SCHEMBL217151

CN(C)CCOc1ccc2nc(-c3nc(C(N)=O)c(C(N)=O)[nH]3)[nH]c2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK2 O96017 8/20 0.57
ACHE P22303 5/20 0.53
DYRK3 O43781 1/20 0.49
MAP4K4 O95819 1/20 0.49
PIM1 P11309 1/20 0.49
RPS6KB1 P23443 1/20 0.49
CSNK2A1 P68400 1/20 0.49
PKN2 Q16513 1/20 0.49
PIM3 Q86V86 1/20 0.49
BRSK1 Q8TDC3 1/20 0.49
AURKB Q96GD4 1/20 0.49
HIPK2 Q9H2X6 1/20 0.49
CLK4 Q9HAZ1 1/20 0.49
MKNK2 Q9HBH9 1/20 0.49
STK17A Q9UEE5 1/20 0.49
MAP4K5 Q9Y4K4 1/20 0.49
HDAC6 Q9UBN7 1/20 0.43
FLT3 P36888 1/20 0.43
PDGFRB P09619 1/20 0.43
PDGFRA P16234 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL215874 0.80 CHEK2 (0.65) CHEK2ACHEPDE3BPDE3A
SCHEMBL21018152 0.78 ACHE (0.81) CHEK2ACHEHDAC6KDM4EALDH1A1
SCHEMBL217152 0.76 CHEK2 (0.47) CHEK2ACHEDYRK3MAP4K4PIM1
SCHEMBL217150 0.76 LMNA (0.50) CHEK2ACHEDYRK3MAP4K4PIM1
SCHEMBL216746 0.75 ACHE (0.57) CHEK2ACHEFLT3PDGFRBPDGFRA
SCHEMBL21017589 0.74 CHEK2 (0.70) CHEK2ACHEHDAC6KDM4EALDH1A1
SCHEMBL21017859 0.73 CHEK2 (0.60) CHEK2ACHEPDGFRBPDGFRAKDM4E
SCHEMBL20982619 0.73 CHEK2 (0.72) CHEK2ACHEKDM4EALDH1A1LMNA
SCHEMBL20982739 0.72 ACHE (0.71) CHEK2ACHEHDAC6KDM4EALDH1A1
SCHEMBL21018064 0.72 ACHE (0.71) CHEK2ACHEHDAC6KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088767-B2 JAK-2 modulators and methods of use EXELIXIS, INC. (US) 2012-01-03 US disclosed